Himalaya Nutrave

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1OTR01013
  • NSEID:
  • BSEID: 544943
INR
116.65
-6.1 (-4.97%)
BSENSE

Oct 09

BSE+NSE Vol: 12000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

12.0 k (-89.54%) Volume

Shareholding (Sep 2026)

FII

7.54%

Held by 2 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

68.13%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 108 Cr ()

stock-summary
P/E

15.00

stock-summary
Industry P/E

36

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

6.60

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Commercial Suit Filed Against The Company

04-Oct-2026 | Source : BSE

Kindly find the enclosed disclosure

Closure of Trading Window

03-Oct-2026 | Source : BSE

Closure of trading window

Announcement under Regulation 30 (LODR)-Investor Presentation

03-Oct-2026 | Source : BSE

Investor presentation FY 2026

Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
5.18
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
1.20%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
7.54%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
36
Price to Book Value
6.60
EV to EBIT
14.37
EV to EBITDA
13.78
EV to Capital Employed
5.57
EV to Sales
2.60
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
38.77%
ROE (Latest)
45.11%
Technicals key factors
Indicator
Weekly
Monthly
Icon
Technical indicator has not been calculated since the stock has been active for a short period
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 2 FIIs (7.54%)

Promoter with highest holding

Bhaveshkumar Jivrajbhai Kakadiya (17.66%)

Highest Public shareholder

Devangkumar R Patel (3.17%)

Individual Investors Holdings

14.68%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Himalaya Nutrave"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Himalaya Nutrave"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Himalaya Nutrave"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Himalaya Nutrave"
  }
]
stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details